Robert M. VanHimbergen, Executive Vice President and CFO of Elanco Animal Health Inc, filed a statement of changes in beneficial ownership on November 3, 2026, disclosing an acquisition of deferred stock units dated October 30, 2026.
Key Highlights
- Reporting person: Robert M. VanHimbergen, identified in the filing as EVP and CFO of Elanco Animal Health Inc (NYSE:ELAN)
- Transaction: Acquisition (Code A) of 8.5438 Deferred Stock Units on October 30, 2026
- Price per unit: $23.06, as stated in the filing
- Post-transaction holdings: 184.4621 Deferred Stock Units held directly following the reported transaction
- Unit structure: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent
- Settlement terms: Units settle in cash or shares following termination of employment or during a specified future year under the Executive Deferral and Stock Match Plan
CFO VanHimbergen's October 2026 Deferred Stock Unit Acquisition at Elanco Animal Health
According to the filing, Robert M. VanHimbergen, serving as Executive Vice President and Chief Financial Officer at Elanco Animal Health Inc, acquired 8.5438 Deferred Stock Units on October 30, 2026. The transaction was recorded under Code A, denoting an acquisition, at a stated price of $23.06 per unit. Following this transaction, VanHimbergen directly held 184.4621 Deferred Stock Units, as reported in Table II of the filing covering derivative securities.
Elanco Animal Health Inc is a company engaged in the animal health sector, trading on the New York Stock Exchange under the ticker ELAN, with its principal offices located at 450 Elanco Circle, Indianapolis, Indiana 46221. The filing was signed by Amy C. Seidel as Attorney-in-Fact for Robert M. VanHimbergen on November 3, 2026, the same date it was filed with the SEC.
The filing explains that each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. According to the filing's explanation of responses, these deferred stock units "settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan." No expiration date or exercisable date fields were populated for these units in the filing. No non-derivative securities transactions were reported in Table I.
What Was Disclosed
The filing disclosed an acquisition of 8.5438 Deferred Stock Units by Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, on October 30, 2026, at $23.06 per unit, bringing his total direct holdings of such units to 184.4621.




Please wait processing your request...